Coagulation Modifying Agents Part 1: Antiplatelets and Anticoagulants Flashcards
PARENTERAL • Heparin Type Products a. Heparin, Enoxaparin b. Argatroban, Fondaparinux c. Warfarin d. Apixaban, Rivaroxaban, Dabigatran
a. Heparin, Enoxaparin
PARENTERAL • Non-Heparin Products a. Heparin, Enoxaparin b. Argatroban, Fondaparinux c. Warfarin d. Apixaban, Rivaroxaban, Dabigatran
b. Argatroban, Fondaparinux
ORAL • Vitamin K Antagonists a. Heparin, Enoxaparin b. Argatroban, Fondaparinux c. Warfarin d. Apixaban, Rivaroxaban, Dabigatran
c. Warfarin
ORAL • NOAC/DOACs a. Heparin, Enoxaparin b. Argatroban, Fondaparinux c. Warfarin d. Apixaban, Rivaroxaban, Dabigatran
d. Apixaban, Rivaroxaban, Dabigatran
◦ Can be used in Pregnant Patients
a. Heparin, Enoxaparin
b. Argatroban, Fondaparinux
c. Warfarin
d. Apixaban, Rivaroxaban, Dabigatran
Heparin
USED TO DVT prophylaxis ◦ DVT/PE treatment (therapeutic) a. Heparin, Enoxaparin b. Argatroban, Fondaparinux c. Warfarin d. Apixaban, Rivaroxaban, Dabigatran
Heparin
The Steps for Heparin SQ
•For subcutaneous injections, use a 20- to 22-gauge needle to withdraw medication from the vial.
Then, change the needle to a smaller needle (25- or 26-gauge, ½ to ⅝ inches long).
•Administer deep subcutaneous injections in the abdomen, ensuring a distance of at least 2
inches from the umbilicus
•Do not aspirate
•Apply gentle pressure for 1 to 2 min after the injection.
•Rotate and record injection sites
dddd
◦ Body- ◦ Petechiae, bruising, hematoma a. Heparin, Enoxaparin b. Argatroban, Fondaparinux c. Warfarin d. Apixaban, Rivaroxaban, Dabigatran
a. Heparin, Enoxaparin
OTHER ADVERSE EFFECTS ◦ Osteoporosis – LONG TERM a. Heparin, Enoxaparin b. Argatroban, Fondaparinux c. Warfarin d. Apixaban, Rivaroxaban, Dabigatran
a. Heparin, Enoxaparin
OTHER ADVERSE EFFECTS ◦ Osteoporosis – LONG TERM a. Heparin, Enoxaparin b. Argatroban, Fondaparinux c. Warfarin d. Apixaban, Rivaroxaban, Dabigatran
a. Heparin, Enoxaparin
b. Argatroban, Fondaparinux
•REVERSAL AGENT/ANTIDOTE • Protamine Sulfate a. Heparin, Enoxaparin b. Argatroban, Fondaparinux c. Warfarin d. Apixaban, Rivaroxaban, Dabigatran
a. Heparin, Enoxaparin
•CONTRA-INDICATIONS ◦ AVOID in epidurals + neurosurgery ◦ Hematoma in the spine can cause swelling which can lead to paralysis a. Heparin, Enoxaparin b. Argatroban, Fondaparinux c. Warfarin d. Apixaban, Rivaroxaban, Dabigatran
a. Heparin, Enoxaparin
b. Argatroban, Fondaparinux
• Pork allergy- from intestinal mucosa from pigs, Pork- religious • Recommend consulting professional a. Heparin, Enoxaparin b. Argatroban, Fondaparinux c. Warfarin d. Apixaban, Rivaroxaban, Dabigatran
a. Heparin, Enoxaparin
b. Argatroban, Fondaparinux
Check aPTT for appropriate range, review CBC (H/H,Plts)
a. Heparin, Enoxaparin
b. Argatroban, Fondaparinux
c. Warfarin
d. Apixaban, Rivaroxaban, Dabigatran
a. Heparin, Enoxaparin
b. Argatroban, Fondaparinux
S/s of bleeding, Monitor Hgb/hct/plts
a. Heparin, Enoxaparin
b. Argatroban, Fondaparinux
c. Warfarin
d. Apixaban, Rivaroxaban, Dabigatran
a. Heparin, Enoxaparin
S/s of bleeding, Monitor Hgb/hct/plts
a. Heparin, Enoxaparin
b. Argatroban, Fondaparinux
c. Warfarin
d. Apixaban, Rivaroxaban, Dabigatran
a. Heparin, Enoxaparin
b. Argatroban, Fondaparinux
Weight based dosing, 80 kg patient
◦ 80 mg SC every 12 hours
a. Heparin, Enoxaparin
b. Argatroban, Fondaparinux
c. Warfarin
d. Apixaban, Rivaroxaban, Dabigatran
Enoxaparin
◦ General adult dose is 5,000 units SC every 8 or 12 hours
a. Heparin, Enoxaparin
b. Argatroban, Fondaparinux
c. Warfarin
d. Apixaban, Rivaroxaban, Dabigatran
Heparin
◦ General adult dose is 5,000 units SC every 8 or 12 hours
a. Heparin, Enoxaparin
b. Argatroban, Fondaparinux
c. Warfarin
d. Apixaban, Rivaroxaban, Dabigatran
Heparin
•USED TO TREAT (Continuous IV drip) • patients who have developed HIT • Hx of HIT with active PE/DVT a. Heparin, Enoxaparin b. Argatroban, Fondaparinux c. Warfarin d. Apixaban, Rivaroxaban, Dabigatran
Argatroban
USED TO TREAT • Continuous IV drip- patients who have developed HIT a. Heparin, Enoxaparin b. Argatroban, Fondaparinux c. Warfarin d. Apixaban, Rivaroxaban, Dabigatran
Argatroban
USED TO TREAT (Subcutaneous injection) • patients who have developed HIT • Hx of HIT with active PE/DVT • DVT/PE prophylaxis or treatment a. Heparin, Enoxaparin b. Argatroban, Fondaparinux c. Warfarin d. Apixaban, Rivaroxaban, Dabigatran
Fondaparinux
Wich cause HIT- Heparin induced thrombocytopenia causes
a. Heparin, Enoxaparin
b. Argatroban, Fondaparinux
c. Warfarin
d. Apixaban, Rivaroxaban, Dabigatran
a. Heparin, Enoxaparin
USED TO TREAT ◦ Mechanical Heart valves (prevent stroke/clot formation) a. Heparin, Enoxaparin b. Argatroban, Fondaparinux c. Warfarin d. Apixaban, Rivaroxaban, Dabigatran
c. Warfarin
PT INR a. Heparin, Enoxaparin b. Argatroban, Fondaparinux c. Warfarin d. Apixaban, Rivaroxaban, Dabigatran
c. Warfarin
ADVERSE EFFECTS ◦ Bleeding (review H/H/Plts)- BOXED WARNING FROM THE FDA a. Heparin, Enoxaparin b. Argatroban, Fondaparinux c. Warfarin d. Apixaban, Rivaroxaban, Dabigatran
c. Warfarin
ADVERSE EFFECTS ◦ Skin Necrosis (<1%) ◦ Protein C a. Heparin, Enoxaparin b. Argatroban, Fondaparinux c. Warfarin d. Apixaban, Rivaroxaban, Dabigatran
c. Warfarin
◦ Protein C
a. Heparin, Enoxaparin
b. Argatroban, Fondaparinux
c. Warfarin
d. Apixaban, Rivaroxaban, Dabigatran
c. Warfarin
ADVERSE EFFECTS ◦ Purple Toe Syndrome a. Heparin, Enoxaparin b. Argatroban, Fondaparinux c. Warfarin d. Apixaban, Rivaroxaban, Dabigatran
c. Warfarin
•CONTRA-INDICATIONS ◦ AVOID in epidurals + neurosurgery a. Heparin, Enoxaparin b. Argatroban, Fondaparinux c. Warfarin d. Apixaban, Rivaroxaban, Dabigatran
a. Heparin, Enoxaparin
b. Argatroban, Fondaparinux
c. Warfarin
• PREGNANCY CATEGORY X • Heparin is safe to use as an alternative a. Heparin, Enoxaparin b. Argatroban, Fondaparinux c. Warfarin d. Apixaban, Rivaroxaban, Dabigatran
c. Warfarin
•REVERSAL AGENTS • Vitamin K/ Phytonadione (Aquamephyton®) a. Heparin, Enoxaparin b. Argatroban, Fondaparinux c. Warfarin d. Apixaban, Rivaroxaban, Dabigatran
c. Warfarin
•REVERSAL AGENTS • KCentra®- Human Clotting Factors II,VII, IX a. Heparin, Enoxaparin b. Argatroban, Fondaparinux c. Warfarin d. Apixaban, Rivaroxaban, Dabigatran
c. Warfarin
•DRUG INTERACTIONS • SSRI’s- Bleed risk • NSAIDS- Bleed risk a. Heparin, Enoxaparin b. Argatroban, Fondaparinux c. Warfarin d. Apixaban, Rivaroxaban, Dabigatran
c. Warfarin
• NSAIDS- Bleed risk (recommend acetaminophen instead!)
a. Heparin, Enoxaparin
b. Argatroban, Fondaparinux
c. Warfarin
d. Apixaban, Rivaroxaban, Dabigatran
c. Warfarin
St. Johns Wort (decreases ? levels)
a. Heparin, Enoxaparin
b. Argatroban, Fondaparinux
c. Warfarin
d. Apixaban, Rivaroxaban, Dabigatran
c. Warfarin
Limit Vitamin K in Diet
a. Heparin, Enoxaparin
b. Argatroban, Fondaparinux
c. Warfarin
d. Apixaban, Rivaroxaban, Dabigatran
c. Warfarin
Start on heparin IV drip and warfarin while in the hospital. Wait until INR is therapeutic
◦ (5 days of overlap warfarin/heparin) before discharge
T or F
T
PATIENT EDUCATION CONTINUED: ▪Instruct patients to do things like use electric shaver, soft bristle toothbrush to reduce risk for a bleed a. Heparin, Enoxaparin b. Argatroban, Fondaparinux c. Warfarin d. Apixaban, Rivaroxaban, Dabigatran
c. Warfarin
Factor Xa Inhibitors
a. Heparin, Enoxaparin
b. Argatroban, Fondaparinux
c. Warfarin
d. Apixaban, Rivaroxaban, Dabigatran
Apixaban, Rivaroxaban
•2)Direct Thrombin Inhibitor –
a. Heparin, Enoxaparin
b. Argatroban, Fondaparinux
c. Warfarin
d. Apixaban, Rivaroxaban, Dabigatran
Dabigatran
• REVERSAL AGENT • Andexanet Alfa (Andexxa®) a. Heparin, Enoxaparin b. Argatroban, Fondaparinux c. Warfarin d. Apixaban, Rivaroxaban, Dabigatran
Apixaban, Rivaroxaban,
? must be given with food
d. Apixaban, Rivaroxaban, Dabigatran
Rivaroxaban
USED TO TREAT: • Atrial fibrillation (non-valvular) a. Heparin, Enoxaparin b. Argatroban, Fondaparinux c. Warfarin d. Apixaban, Rivaroxaban, Dabigatran
Dabigatran
REVERSAL AGENT Praxbind® (Idarucizumab) a. Heparin, Enoxaparin b. Argatroban, Fondaparinux c. Warfarin d. Apixaban, Rivaroxaban, Dabigatran
Dabigatran
CONTRA-INDICATIONS – Same as other anticoagulants – Active Bleeding – Peptic Ulcer Disease – Neurosurgery/epidural a. Heparin, Enoxaparin b. Argatroban, Fondaparinux c. Warfarin d. Apixaban, Rivaroxaban, Dabigatran
All
Must be given with full glass of water. If GI upset occurs even with full glass of water, can give with meals
a. Heparin, Enoxaparin
b. Argatroban, Fondaparinux
c. Warfarin
d. Apixaban, Rivaroxaban, Dabigatran
Dabigatran
P2Y12 ADP Receptor
Antagonists
a. Aspirin
b. Clopidogrel, Ticagrelor
b. Clopidogrel, Ticagrelor
Primary: (Heart + Brain) • Coronary Stenting • Acute MI/ Angina • Stroke (Atrial fibrillation) • TIA’s a. Aspirin b. Clopidogrel, Ticagrelor
a. Aspirin
• Pediatrics- Kawasaki (NEVER GIVE TO CHILDREN- outside of this disease)
a. Aspirin
b. Clopidogrel, Ticagrelor
a. Aspirin
-A sthma
-S alicylism (N/V/D, rapid breathing- hyperventilation)
-P remature closing of PDA/Platelet disaggregation/ Peptic Ulcer
Disease
-I ntestinal bleeding
-R eye’s Syndrome/Ringing in the ears/Renal Impairment/Rapid
Breathing/RESPIRATORY ALKALOSIS
-I diosyncratic Reaction
-N oise (Tinnitus)/Nephropathy
a. Aspirin
b. Clopidogrel, Ticagrelor
a. Aspirin
Avoid with Reye Syndrome
a. Aspirin
b. Clopidogrel, Ticagrelor
a. Aspirin
CONTRA-INDICATIONS – Active Bleeding – Peptic Ulcer Disease – Children (especially if infected with a virus) a. Aspirin b. Clopidogrel, Ticagrelor
a. Aspirin
– Peptic Ulcer Disease
a. Aspirin
b. Clopidogrel, Ticagrelor
a. Aspirin
• Percutaneous Coronary Intervention (STENT placement)
a. Aspirin
b. Clopidogrel, Ticagrelor
b. Clopidogrel, Ticagrelor
•Thrombotic Thrombocytic Purpura (TTP)
a. Aspirin
b. Clopidogrel, Ticagrelor
b. Clopidogrel, Ticagrelor
CONTRA-INDICATIONS – Active Bleeding – Peptic Ulcer Disease a. Aspirin b. Clopidogrel, Ticagrelor c. alteplase “plase”
b. Clopidogrel, Ticagrelor
USED TO TREAT –Ischemic Stroke –Massive Pulmonary Embolism –Massive Myocardial Infarction –Central venous catheter clearance (tiny dose a. Aspirin b. Clopidogrel, Ticagrelor c. alteplase “plase”
c. alteplase “plase”
Tissue Plasminogen Activator (TPA) Clot bluster
a. Aspirin
b. Clopidogrel, Ticagrelor
c. alteplase “plase”
c. alteplase “plase”
Most STROKE guidelines allow within 3 to 4.5 hours of symptom ONSET a. Aspirin b. Clopidogrel, Ticagrelor c. alteplase “plase”
c. alteplase “plase”
c. alteplase “plase” Most STROKE guidelines allow within ? to ? hours of symptom
ONSET
3 to 4.5 hours
CONTRA-INDICATIONS ◦ Active Bleeding ◦ GI Bleed/ Peptic Ulcer Disease ◦ On active anticoagulants ◦ Hemorrhagic Stroke ◦ Clotting Disorders, etc. a. Aspirin b. Clopidogrel, Ticagrelor c. alteplase “plase”
c. alteplase “plase”
POST ADMINISTRATION:
Minimize bruising or bleeding by limiting venipunctures and
subcutaneous/IM injections. Hold direct pressure to injection
site or ABG site for up to 30 min until oozing stops
a. Aspirin
b. Clopidogrel, Ticagrelor
c. alteplase “plase”
c. alteplase “plase”
Bracelet: Some facilities give patients bracelet to wear that
says “No Anticoagulants, No Antiplatelets 24 hours after
Alteplase Administration” because bleed risk is so high
a. Aspirin
b. Clopidogrel, Ticagrelor
c. alteplase “plase”
c. alteplase “plase”